Schadendorf D - Search Results

1

Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.

Röhn TA, Schadendorf D, Sun Y, Nguyen XD, Roeder D, Langen H, Vogt AB, Kropshofer H. Röhn TA, et al. Among authors: schadendorf d. Eur J Immunol. 2005 Oct;35(10):2826-39. doi: 10.1002/eji.200526299. Eur J Immunol. 2005. PMID: 16163671 Free article.

2

A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope.

Röhn TA, Reitz A, Paschen A, Nguyen XD, Schadendorf D, Vogt AB, Kropshofer H. Röhn TA, et al. Among authors: schadendorf d. Cancer Res. 2005 Nov 1;65(21):10068-78. doi: 10.1158/0008-5472.CAN-05-1973. Cancer Res. 2005. PMID: 16267033

3

Functional HLA-DM on the surface of B cells and immature dendritic cells.

Arndt SO, Vogt AB, Markovic-Plese S, Martin R, Moldenhauer G, Wölpl A, Sun Y, Schadendorf D, Hämmerling GJ, Kropshofer H. Arndt SO, et al. Among authors: schadendorf d. EMBO J. 2000 Mar 15;19(6):1241-51. doi: 10.1093/emboj/19.6.1241. EMBO J. 2000. PMID: 10716924 Free PMC article.

4

Detection of spontaneous CD4+ T-cell responses in melanoma patients against a tyrosinase-related protein-2-derived epitope identified in HLA-DRB1*0301 transgenic mice.

Paschen A, Song M, Osen W, Nguyen XD, Mueller-Berghaus J, Fink D, Daniel N, Donzeau M, Nagel W, Kropshofer H, Schadendorf D. Paschen A, et al. Among authors: schadendorf d. Clin Cancer Res. 2005 Jul 15;11(14):5241-7. doi: 10.1158/1078-0432.CCR-05-0170. Clin Cancer Res. 2005. PMID: 16033842

5

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.

Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. Nestle FO, et al. Among authors: schadendorf d. Nat Med. 1998 Mar;4(3):328-32. doi: 10.1038/nm0398-328. Nat Med. 1998. PMID: 9500607 Clinical Trial.

6

Autologous, allogeneic tumor cells or genetically engineered cells as cancer vaccine against melanoma.

Schadendorf D, Paschen A, Sun Y. Schadendorf D, et al. Immunol Lett. 2000 Sep 15;74(1):67-74. doi: 10.1016/s0165-2478(00)00251-0. Immunol Lett. 2000. PMID: 10996630 Review.

7

In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells.

Sun Y, Möller P, Berking C, Schlüpen EM, Volkenandt M, Schadendorf D. Sun Y, et al. Among authors: schadendorf d. Immunology. 1999 Dec;98(4):535-40. doi: 10.1046/j.1365-2567.1999.00902.x. Immunology. 1999. PMID: 10594685 Free PMC article.

8

Differentiation of monocyte-derived dendritic cells under the influence of platelets.

Nguyen XD, Müller-Berghaus J, Kälsch T, Schadendorf D, Borggrefe M, Klüter H. Nguyen XD, et al. Among authors: schadendorf d. Cytotherapy. 2008;10(7):720-9. doi: 10.1080/14653240802378912. Cytotherapy. 2008. PMID: 18985478

9

Gene-based immunotherapy of skin cancers.

Sun Y, Schadendorf D. Sun Y, et al. Among authors: schadendorf d. Recent Results Cancer Res. 2002;160:170-84. doi: 10.1007/978-3-642-59410-6_21. Recent Results Cancer Res. 2002. PMID: 12079212 Review.

10

Segregation of effector mechanisms in a tumour-specific CD8+ T-cell clone correlates with CD30 expression.

Sun Y, Song M, Maeurer MJ, Schadendorf D. Sun Y, et al. Among authors: schadendorf d. Scand J Immunol. 2001 Sep;54(3):314-20. doi: 10.1046/j.1365-3083.2001.00971.x. Scand J Immunol. 2001. PMID: 11555396 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,077 results

Search Page